ESTRO Guide 2018

ECCO 2018 European Cancer Summit 7-9 September 2018 | Vienna, Austria

• Organisation of Cancer Care Delivery Focusing on the patient voice to determine an agreed vision for guiding and supporting patients through diagnosis, treatment and follow-up in a world facing an ageing population, increasing survivorship and a technological revolution in e-health resources. JOIN US in Vienna to shape the future of European cancer care! For the latest information, please visit www.eccosummit.eu

The ECCO 2018 European Cancer Summit will be held in Vienna (Austria) on 7-9 September 2018, bringing worldwide leaders from the cancer healthcare, patient advocacy and stakeholder communities together in a uniquemultidisciplinary forum. In a fast-paced environment of ever-increasing complexity, the way cancer care is delivered evolves, and ECCO 2018 allows all stakeholders to gather at this meeting to outline the best way forward for cancer patients in Europe fromamulti-disciplinary perspective. Facilitating the mission and vision of ECCO – European Cancer Organisation which is to improve patient outcomes, the programme is developed and devised by ECCO and its 25member societies. ECCO members, representing over 170,000 oncology professionals, play an integral and invaluable role in developing the Summit programme.

Connecting science with real life by driving policy evolution at the highest political level, the Summit will: • Debate leading-edge ideas on outcomes research, health economics and organisation of cancer care delivery • Determine consensus resolutions for improving health systems • Decide on an action plan for the way forward to ensure ideas translate into policies that will impact daily clinical practice. INTEGRATINGMULTIDISCIPLINARITY AND PATIENT PERSPECTIVE ACROSS THREE PILLARS: • Outcome Research Using real-world data to observe how new treatments and diagnostic modalities have performed in the clinic • Health Economics of Cancer Care Developing consensus resolutions on the cost- effectiveness and implementation of cancer molecular characterisation and new cancer diagnostics and therapies

CONFERENCES

152